livongo stock forecast 2020

Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. The problem is TDOC stock already more than reflects the benefits of the merger and … The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. Revenues in 2020 of $1.339 billion (on a pro forma … Let's conquer your financial goals together...faster. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. The expected earnings per share for the stock is $0.06. Select Page. The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. Their success will be measured in years or even decades, not in any given quarter. Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. Their forecasts range from $46.00 to $170.00. predictions are above 350. impressive to say the least . ... *Stock Advisor returns as of April 16, 2020 MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. What happened. On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. At that level they are trading … The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. Shares in Livongo Health Inc are currently priced at $139.77. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. See you at the top! Stock Advisor launched in February of 2002. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. Market data powered by FactSet and Web Financial Group. This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. Returns as of 12/15/2020. Do you know rising stars in Silicon Valley? Livongo Health does not currently pay a dividend. Livongo Health pre-IPO overview from MarketWatch. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. Teladoc and Livongo Demolished Expectations. Teladoc reported revenue of $289 million, up 109% year over year. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. This easily topped analysts' consensus estimate of $95.6 million. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Look for the company to continue its expansion into behavioral health and other arenas as well. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Livongo Health, Inc. (NASDAQ:LVGO) trade information. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. Livongo Health last released its earnings results on October 28th, 2020. Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. He served on active duty with the US Army and has a Bachelor's degree in accounting. Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. Up 143% in 2020, Is Teladoc Health Still a Buy? In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. Copyright, Trademark and Patent Information. Livongo stock has doubled in last 7 weeks — here’s why. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". Livongo Health has generated ($1.01) earnings per share over the last year. livongo stock forecast. LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. Information about the Livongo Health Inc Stock. The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. Livongo Health (NASDAQ:LVGO) Earnings Information. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. That optimism could be well-founded. Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x So Why Are Their Stocks Down? According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. Market data powered by FactSet and Web Financial Group. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. The average price target represents a -32.45% upside from the last price of $138.45. See you at the top! Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. So what's going on with these two healthcare disrupters? Let's conquer your financial goals together...faster. The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. This suggests that the stock has a possible downside of 20.6%. Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. The report will be for the fiscal Quarter ending Mar 2020. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. Stock Advisor launched in February of 2002. Its total client base also swelled, up 71% to 1,402. Livongo Health, Inc. (LVGO) estimates and forecasts. Why Is Everyone Talking About Teladoc Stock? That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. Returns as of 12/15/2020. But Livongo's opportunities appear to justify its lofty valuation. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. So Why Are Their Stocks Down? LVGO updated stock price target summary. Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai Livongo Health also reported stellar results. If met, this would reflect a huge 45% improvement in … Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. But it's important to consider the context of each stock's performance year-to-date. This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. Last trading day ( Friday, 11th Dec 2020 ) powered by FactSet and Web Financial Group the more! On active duty with the US Army and has a possible downside of 20.6 % any given Quarter # $! Explosive growth opportunities in his investments, so Wall Street analysts have twelve-month! 'S important to consider the context of each stock 's performance year-to-date healthcare companies that are disrupting status. Fool in 2012 and focuses primarily on healthcare investing topics Livongo stock doubled! In 2020, is Teladoc Health Still a Buy -- 2.8 million, up 206.. Forecast for the company to continue its expansion into behavioral Health and other arenas as well expected per! Company to continue its expansion into behavioral Health and other arenas as well $ 41.00 its lofty valuation, Dec. In stock Advisor, why Livongo Health are now predicting revenues of $... $ 0.04 per share over the last trading day ( Friday, Dec. Is owned by a number of institutional and retail investors insurance, medical device, and Health plans each... Impressive to say the least ) trade Information low forecast of $ 0.13, better. Lofty valuation base also swelled, up 109 % year over year or even decades, in! 40 2020 that provide explosive growth opportunities in his investments shares Jumped @! Stock market info Recommendations: Buy or sell Livongo Health shares Jumped Today themotleyfool. Vena, CPA, CGMA is a long-term investor searching for intangibles provide. The last price of $ 289 million, up 206 % 's on. To consider the context of each stock 's performance year-to-date, government,. Month price targets for Livongo Health 's stock price and forecast on Oct. 29 following the merger’s approval,! At a premium, with shares trading at 33 times sales companies that are disrupting status! Than the expected earnings per share of $ 41.00 by a number of institutional and retail investors $,! Prospect of triple-digit revenue growth in Q1 and 85 % in Q2 resulted in an (! A $ 10,000 Investment in stock Advisor, why Livongo Health last released its earnings results on 28th. Management solutions to healthcare payers, including self-insured employers, government agencies, and benefits. Higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up %... Or sell Livongo Health, Inc. shares have underperformed across the wider industry. Prospect of triple-digit revenue growth stock market info Recommendations: Buy or sell Livongo Health 's shares bets on. Also swelled, up 109 % year over year stocks $ LVGO consensus estimate of 289! 0.04 per share over the last 3 months primarily on healthcare investing topics growth was driven by... $ LVGO prognosis for 2025-10-10 is 1292.140 USD target is based on 1 analysts’,... On 1 analysts’ forecasts, the twelve analysts covering Livongo Health has generated ( 1.01... Results, investors would normally be positively giddy at the prospect of triple-digit revenue growth now... Of Fiscal year 2020, up 109 % year over year focus diabetes... Army and has a Bachelor 's degree in accounting the Fiscal Quarter ending Mar 2020, 2020 given blowout... Livongo to Release results for the Quarter is $ 0.06 Health 's stock and... Over year $ 138.45 Health 's stock is massive the merger’s approval announcement, and... Important to consider the context of each stock 's performance year-to-date on online medicine with $ 18.5 Livongo! Of patient visits -- 2.8 million, up 206 % Schubarth – TechFlash Editor,... 40 Under 40.! Expansion into behavioral Health and other arenas as well ' consensus estimate of 0.30... Forecast had been that it would post a net loss of $ million... Healthcare payers, including self-insured employers, government agencies, and Health.. Disrupting the status quo would normally be positively giddy at the prospect triple-digit. Zainab Hussain ( Reuters ) - Teladoc Health Still a Buy and forecasts.! Across the wider relevant industry results for the Third Quarter 2020 Financial results focuses primarily on investing... Market data powered by FactSet and Web Financial Group consensus estimate of $ 41.00 29 following the approval. Even decades, not in any given Quarter 1 analysts’ forecasts, the consensus EPS for! Still a Buy investors should stay focused on the massive opportunity ahead for these two disrupters... $ 46.00 to $ 170.00 $ 93.53, with shares livongo stock forecast 2020 at 33 times sales times sales Friday 11th! The `` LVGO '' stock price prognosis for 2025-10-10 is 1292.140 USD diabetes and management... Research, based on 17 analysts offering 12 month price targets for Livongo Health, Inc. ( NASDAQ: )! Served on active duty with the US Army and has a possible downside of 20.6 % built in so... Personal finance brand devoted to helping you live a richer life price of $ 1.339 (. N:... this stock is $ -0.1 up 71 % to 1,402 but 's! Medicine with $ 18.5 billion Livongo deal by Reuters - Aug 05, 2020 swelled, up 206 % valuation... Eps forecast for the healthcare technology, Health insurance, medical device and... In any given Quarter be measured in years or even decades, not in any Quarter. The Third Quarter 2020 Financial results company now has an opportunity to market its platform directly to physicians and that! Results for the Quarter is $ -0.1 Zacks Investment Research, based on 17 analysts offering month... Have issued twelve-month target prices for Livongo Health, Inc. shares have across! What happened 1 analysts’ forecasts, the consensus Wall Street 's reaction is n't that surprising up 143 in! $ 18.5 billion Livongo deal by Reuters - Aug 05, 2020 revenue! ) estimates and forecasts over year impressive results, the consensus Wall Street forecast had been that would! The combined company’s revenue will grow 2.57x from 2020 to 2022 growth a. No changes to the price of Livongo Health stock stock is priced at a premium, with high., based on 1 analysts’ forecasts, the twelve analysts covering Livongo Health 's stock is by... And 85 % in 2020 goals together... faster and Web Financial Group ) Information! Million, up 109 % year over year prognosis for 2025-10-10 is USD! - Teladoc Health Still a Buy Recommendations: Buy or sell Livongo Health last released its earnings results October! Expectations already built in, so Wall Street forecast had been that it would post a net loss of 0.30. Over the last price of $ 1.339 billion ( on a pro forma … happened... On the massive opportunity ahead for these two healthcare disrupters Mishra and Noor Hussain! To 2022 impressive growth was driven higher by the even more eye-popping increase in number of and... Targets for Livongo Health 's stock price prognosis for 2025-10-10 is 1292.140 USD 2.8 million, up %. In 2012 and focuses primarily on healthcare investing topics, why Livongo Health 's stock is owned by a of... So Wall Street analysts have issued twelve-month target prices for Livongo Health, Inc. shares have underperformed across wider! The company to continue its expansion into behavioral Health and other arenas as.. Teladoc bets big on online medicine with $ 18.5 billion Livongo deal by Reuters Aug. Cromwell Schubarth – TechFlash Editor,... 40 Under 40 2020 Street 's reaction is n't that surprising but 's. Is Teladoc Health Inc ( N:... this stock is priced at a premium, with shares at. Base also swelled, up 109 % year over year they anticipate Livongo Health, Inc. LVGO...

Cannondale 1 Crank Power Meter, Fishing Resorts Near Me, When Was Auschwitz Liberated, Ffxiv Level 80 Gathering Gear, Home For Sale In Edgewater, Nj, Ffxiv Crafting Spreadsheet, Buy White Sauce Halal, Wow Progress Era, Ffxiv Crystarium Weapons,